Q4 2019 Holdings
Filed 2020-02-14 | 12 holdings | $266.2K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Spdr Series Trust(XBI)Put | S&P BIOTECH | 78464A870 | $118.9K | 1,250,000 | 44.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $28.4K | 396,899 | 10.7% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $19.1K | 1,922,570 | 7.2% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $17.8K | 4,966,820 | 6.7% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $15.3K | 1,166,736 | 5.7% |
| Galapagos NV(GLPG) | SPON ADR | 36315X101 | $14.9K | 71,967 | 5.6% |
| Merus N V | COM | N5749R100 | $14.6K | 1,038,746 | 5.5% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $13.5K | 614,436 | 5.1% |
| Spero Therapeutics Inc(SPRO) | COM | 84833T103 | $11.1K | 1,154,356 | 4.2% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $11.0K | 268,778 | 4.1% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.4K | 72,273 | 0.5% |
| Morphosys AG | SPONSORED ADS | 617760202 | $217 | 6,080 | 0.1% |